#BeDensiTPro #TappedDensity #PowderFlow #PharmaQC #ParticleCharacterisation #QualityControl #Meritics #LabInnovation #USP #ISO #ASTM #PhEu To view or add a comment, sign in D&O premiums in biotech keep rising for a simple reason: one bad clinical trial can wipe out market cap overnight, and the shareholder lawsuits often follow
This dual GLP-1 and GIP receptor agonist, licensed in the UK for type 2 diabetes and weight management, can cause dizziness through several mechanisms including blood glucose fluctuations, blood pressure changes, and gastrointestinal effects leading to dehydration
215 Herein, we describe the multiple possibilities whereby an enhanced cysteine transport and metabolism enables various types of cancer cells to adapt to the challenging tumour microenvironment, and to thrive, proliferate and acquire chemoresistance
Nearly one in four, 23% specifically, lost 30% or more of their body weight
Why can't we just 'eyeball' it
J Diabetes (2015) 7(3):32939